Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:tumor_classification
|
| gptkbp:appliesTo |
central nervous system tumors
|
| gptkbp:criteria |
increased cellularity
no mitotic activity nuclear atypia |
| gptkbp:describes |
intermediate malignancy tumors
|
| gptkbp:educationLevel |
2
|
| gptkbp:example |
gptkb:diffuse_astrocytoma
gptkb:oligodendroglioma ependymoma |
| gptkbp:introduced |
gptkb:World_Health_Organization
|
| gptkbp:partOf |
gptkb:World_Health_Organization_tumor_grading_system
|
| gptkbp:prognosis |
better than Grade III or IV
|
| gptkbp:progressionRisk |
may progress to higher grade
|
| gptkbp:recurrenceRisk |
moderate
|
| gptkbp:treatment |
gptkb:radiation_therapy
surgery chemotherapy |
| gptkbp:usedBy |
oncologists
neurosurgeons neuropathologists |
| gptkbp:usedUntil |
1979
|
| gptkbp:bfsParent |
gptkb:WHO_Grade_III
|
| gptkbp:bfsLayer |
10
|
| https://www.w3.org/2000/01/rdf-schema#label |
WHO Grade II
|